; medication administration, dispensing, and monitoring; and screening. (iv) One of the following products (or such other products approved after the date of the enactment of this subsection by the Food and Drug Administration for the purpose of maintenance or detoxification treatment), as determined appropriate for the individual by an appropriately licensed clinician for the treatment of such individual: (I) Methadone products. (II) Buprenorphine products. (III) Naltrexone products. (2) Opioid treatment program The term opioid treatment program means an opioid treatment program (as defined in section 8.2 of title 42 of the Code of Federal Regulations, or any successor regulation) that— (A) has in effect an opioid treatment program certification (as defined in such section); (B) has in effect a certification by the Substance Abuse and Mental Health Services Administration for such a program; and (C) is accredited by an accrediting body approved by the Substance Abuse and Mental Health Services Administration. (3) Medication-assisted treatment The term medication-assisted treatment means the use of medications, in combination with counseling, behavioral therapies, and toxicology testing, to provide a comprehensive approach to the treatment of substance use disorders. . (c) Payment (1) In general Section 1833(a)(1) of the Social Security Act ( 42 U.S.C. 1395l(a)(1) ) is amended— (A) by striking and (BB) and inserting (BB)